Broadband Symptom Validity Testing: Evaluating Contemporary Challenges and Symptom-Domain Specificity

Abstract Purpose of Review Over-reporting is a form of response bias involving the exaggeration or fabrication of symptoms and impairment. Symptom validity tests (SVTs), including standalone measures and validity scales embedded within broadband personality inventories, are commonly used to assess over-reporting. Recent SVT development has increasingly emphasized symptom-domain specificity, including cognitive, somatic, and psychological presentations. This review examines current advances and challenges in symptom validity assessment, with particular attention to whether over-reporting indicators demonstrate meaningful domain-specific distinctions. Recent Findings Evidence regarding symptom-domain specificity remains mixed. Although some findings suggest that SVTs may differentially detect particular symptom presentations, other research indicates that these measures generally perform within a common range of over-reporting effects and do not consistently demonstrate the expected relationships between symptom domain and assessment context. To further evaluate these distinctions, we re-analyzed data from an independent meta-analysis of MMPI-2-RF over-reporting validity scales and conducted a random-effects meta-analysis of interscale correlations among MMPI-2-RF over-reporting indicators reported across the empirical literature. Across these complementary analyses, over-reporting indicators demonstrated substantial similarities in performance despite their proposed domain distinctions. Summary Current evidence raises questions about the degree to which symptom-domain distinctions among over-reporting indicators reflect meaningfully separable constructs. Greater attention to construct definition, criterion selection, comparative scale performance, and multivariate patterns of responding is needed to determine when domain-specific interpretations are empirically warranted. Methodological and analytic improvements in these areas may strengthen the construct validity, clinical utility, and interpretive precision of symptom validity assessment.